Skip to main content

Advertisement

Table 2 Clinicopathological data of patients with ovarian cancer

From: Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer

Variable Ovarian carcinoma
Total 75 (100)
Ascites 52 (69)
No ascites 13 (17)
No data (ascites) 10 (13)
Histological grade  
1 12 (16)
2 28 (37)
3 35 (47)
Stage  
I 10 (13)
II 6 (8)
III 42 (56)
IV 17 (23)
Primary residual tumor  
None 27(36)
</=1 cm 9 (12)
> 1 cm 37 (49)
No data 2 (3)
Chemotherapy response  
Complete response 54 (72)
Partial response 4 (5)
Stable disease 2 (3)
Progressive disease 4 (5)
No chemotherapy 4 (5)
No data 7 (10)
Tumor recurrence  
No recurrence 18 (24)
Recurrence 43 (58)
No data 14 (19)
Patient status  
Dead, ovarian cancer 44 (59)
Alive 29 (39)
Unknown 2 (3)
Median follow-up time, months 63 [0–162]
  1. Values are n (%).
  2. Values in square brackets indicate range.